A better understanding of the structure and function of the cell membrane and its components is providing drug developers with new avenues for breaching the cell's outer defenses to deliver drugs or DNA The cell membrane has a tough job. A mere 7 to 10 nanometers thick, this jittery association of lipids and proteins has two seemingly incompatible responsibilities: to prevent the inside and outside of a cell from mixing and yet allow specific molecules to enter the cell and others to exit. Failure to carry out either mission means certain death for a cell. But success can also have its negative consequences when the cell membrane bars entry to a drug searching for its therapeutic target.
imagine all the ways we can use cell-specific transport mechanisms in medicine," says environmental toxicologist Ned Ballatori of the University of Rochester School of Medicine in New York state, who has been studying how transporters help clear the body of toxic chemicals.
Hijacking the transporters Plenty of places in the body are for all intents and purposes unreachable, at least as far as many potential drugs are concerned. The vast majority of drugs that are now injected, such as the antibiotic vancomycin, cannot break through the membrane of the cells that line the digestive system, which means they cannot be taken in pill form.
Tunneling in. Rather than use an existing transporter, a group at Scripps is constructing artificial passageways through the cell membrane using self-assembling peptide nanotubes.
Others never make it out of the bloodstream or past the tightly packed band of cells known as the blood-brain barrier. In each case, the largely impermeable cell membrane is the culprit. Those molecules that do cross the membrane, such as necessary nutrients and hormones, do so courtesy of transporters embedded in the membrane-molecular portals, if you will, that ferry in molecules meeting specific criteria for size, charge, or chemical composition.
Hijacking a transporter seems a promising way to get a drug across the cell membrane, "but being able to do that assumes that you know a great deal about these carrier proteins, including their distribution on various organs and cell types and their specificity [ which specific molecules bind depending on their chemical structure and polarity. Swaan says his group has successfully used this model to modify several molecules so they can slip into cells through the bile acid transporter.
A second approach, taken by Amidon's group and others, has been to synthesize hundreds of molecules to determine the kinds of chemical groups that members of PEPT1 will carry across the membrane using an in vitro model system. With this information in hand, the Michigan team created so-called prodrugs-a chemically modified form of drug that gets converted into the active form by enzymes present in a z cell-of the antiviral agents acyclovir and | AZT that increased the intestinal absorption Q of these drugs from three-to 10-fold. 
